Kay Tetzlaff
MD, Physician, Senior Executive
Mainz
Summary
Experienced and strategic leader with customer centric drug development expertise and analytics skills coupled with more than 20 years of experience. Skilled in clinical development and medical affairs with strong background in respiratory and inflammation medicine. Results-oriented executive recognized for collaborative leadership and employee development, excellent team builder and leader of initiatives.
Overview
22
22
years of professional experience
9
9
years of post-secondary education
Work History
VP, Medicine Inflammation
Boehringer Ingelheim International GmbH
Ingelheim
07.2019 - Current
- Built strong medical organization in new therapeutic area comprising approx. 70 full time employees
- Expanded respiratory franchise and increased market share and revenues of OFEV in pulmonary fibrosis > 2 bio. Progressed strong asset portfolio across clinical development stages in inflammatory bowel diseases, rheumatology, and dermatology.
- Submitted and launched first for Boehringer Ingelheim asset in rare disease with more than 18 months acceleration.
- Spearheaded cross-functional initiatives across departments to achieve business goals for bottom-line profits.
- Evaluated product development strategies and prepared alternative approaches to goal achievement.
- Collaborated with senior management to develop strategic initiatives and long term goals
- Oversaw hiring, adding valuable, talented professionals to strengthen management team
- Established performance goals for department and outlined processes for achievement
- Mitigated regulatory risks by overseeing adherence to insurance and safety regulations
VP, Respiratory and Biosimilars
Boehringer Ingelheim GmbH
Ingelheim
11.2017 - 07.2019
Assoc. Head of Medicine, Respiratory Medicine
Boehringer Ingelheim GmbH
Ingelheim Am Rhein, RP
04.2015 - 10.2017
Senior Clinical Program Lead, Respiratory Medicine
Boehringer Ingelheim GmbH
Ingelheim Am Rhein, RP
07.2012 - 07.2015
Executive Director, CDMA Respiratory
Boehringer Ingelheim Pharmaceuticals
Ridgefield, CT
03.2012 - 07.2012
Director, Respiratory Medicine
Boehringer Ingelheim Pharmaceuticals
Ridgefield, CT
06.2007 - 02.2012
Group Head, Respiratory Clinical Research
Boehringer Ingelheim Pharma GmbH & Co KG
Biberach An Der Riss, BW
07.2000 - 05.2007
Education
Medicine
University of Hamburg Medical School
Hamburg, HH 04.1981 - 05.1987
High School Diploma -
Hebbelschule
Kiel 07.1977 - 06.1980
Skills
Talent recruiting
undefinedTimeline
VP, Medicine Inflammation
Boehringer Ingelheim International GmbH
07.2019 - Current
VP, Respiratory and Biosimilars
Boehringer Ingelheim GmbH
11.2017 - 07.2019
Assoc. Head of Medicine, Respiratory Medicine
Boehringer Ingelheim GmbH
04.2015 - 10.2017
Senior Clinical Program Lead, Respiratory Medicine
Boehringer Ingelheim GmbH
07.2012 - 07.2015
Executive Director, CDMA Respiratory
Boehringer Ingelheim Pharmaceuticals
03.2012 - 07.2012
Director, Respiratory Medicine
Boehringer Ingelheim Pharmaceuticals
06.2007 - 02.2012
Group Head, Respiratory Clinical Research
Boehringer Ingelheim Pharma GmbH & Co KG
07.2000 - 05.2007
Medicine
University of Hamburg Medical School
04.1981 - 05.1987
High School Diploma -
Hebbelschule
07.1977 - 06.1980
Similar Profiles
Neja KavčičNeja Kavčič
Office Assistant at BOEHRINGER INGELHEIM RCV GMBH & CO KG, PodružnicaOffice Assistant at BOEHRINGER INGELHEIM RCV GMBH & CO KG, Podružnica
RAHUL ARYARAHUL ARYA
Portfolio Manager, Project Manager, Validation Manager and Consultant at Boehringer Ingelheim Pharma GmbH & Co. KGPortfolio Manager, Project Manager, Validation Manager and Consultant at Boehringer Ingelheim Pharma GmbH & Co. KG
Taiana BrumTaiana Brum
Demand Planning Manager at Boehringer IngelheimDemand Planning Manager at Boehringer Ingelheim